吉田健一郎 | Tokushima Institute Taiho Pharmaceutical Co. Ltd.

スポンサーリンク

概要

関連著者

もっと見る

著作論文

33 新規抗腫瘍性抗生物質C-1027のクロモフォアの構造(口頭発表の部)
Antitumor Agents. II : Regio- and Stereospecific Syntheses of 1-β-Alkyl-1-desoxypodophyllotoxin Derivatives and Biological Activity
Alkaline and Neutral Degradation of Cefodizime (THR-221) and Structural Elucidation of the Products. II.
Acidic Degradation of Cefodizime (THR-221) and Structural Elucidation of the Products. I
Degradation of β-Lactamase Inhibitor (2S, 3R, 5S)-3-Methyl-7-oxo-3-(1H-1,2,3-triazol-1-yl-methyl)-4-thia-1-azabicyclo[3.2.0]-heptane-2-carboxylic Acid 4,4-Dioxide (YTR-830H) in the Solid State : Structural Elucidation
Degradation of β-Lactamase Inhibitor, (2S, 3R, 5S)-3-Methyl-7-oxo-3-(1H-1,2,3-triazol-1-yl-methyl)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid 4,4-Dioxide (YTR-830H), in Aqueous Solutions and Alkaline Methanol Solution : Pathway and Structural Elu

スポンサーリンク